Skip to content

Comparison of the analgesic effects of ultrasound-guided intercostal plane block of external oblique muscle and intercostal transverse muscle plane block of lower abdomen for laparoscopic liver resection

Comparison of the analgesic effects of ultrasound-guided intercostal plane block of external oblique muscle and intercostal transverse muscle plane block of lower abdomen for laparoscopic liver resection

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600121649
Enrollment
Unknown
Registered
2026-04-01
Start date
2026-04-01
Completion date
Unknown
Last updated
2026-04-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None

Interventions

EOIB group:Perform bilateral intercostal block of the external oblique muscles between the midline of the clavicle and the anterior axillary line on the 6th rib, with 20 ml of 0.4% ropivacaine on each
TAPB group:Undergoing ultrasound-guided transversus abdominis muscle plane block, performed below the rib margin, with 20 ml of 0.4% ropivacaine on each side

Sponsors

Tongji Hospital Affiliated to Tongji Medical College, Huazhong University of Science and Technology
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. ASA grades I-III; 2. Age range: 18-70 years old; 3.BMI 18.5~30 kg/m^2; 4. Selective laparoscopic liver resection; 5. The informed consent form has been signed.

Exclusion criteria

Exclusion criteria: 1. Daily use of opioid analgesics or history of opioid abuse; 2. The situation where nerve block cannot be performed, such as skin infection at the puncture site; 3. Allergic to any of the drugs used in the study, or with a history of allergies; 4. Having cognitive impairment, mental or neurological disorders, motor or sensory deficits, and inability to cooperate; 5. Severe coagulation dysfunction; 6. Severe kidney, liver, lung, or heart dysfunction; 7. Participated in other clinical trials within the 3 months prior to enrollment in the study.

Design outcomes

Primary

MeasureTime frame
Cumulative area under the curve at rest 24 hours after surgery Visual Analog Scale AUC VAS;

Secondary

MeasureTime frame
AUC VAS at rest and cough at 1 h, 2 h, 4 h, and 8 h postoperatively;VAS scores at rest and cough state at 1 h, 2 h, 4 h, 8 h, and 24 h postoperatively;The frequency of salvage analgesia, cumulative opioid dosage, and adverse reactions at 1 h, 2 h, 4 h, 8 h, and 24 h after surgery;Preoperative and postoperative liver and kidney function on days 1 and 3;Preoperative and postoperative day 1 neutrophil/lymphocyte ratio, platelet/lymphocyte ratio, and lymphocyte/monocyte ratio, etc;QoR-15 scores before and 1 day after surgery;Postoperative retention time of abdominal drainage tube, length of hospital stay, etc;

Countries

China

Contacts

Public ContactYi Zhang

Tongji Hospital Affiliated to Tongji Medical College, Huazhong University of Science and Technology

yi_zhang18@tjh.tjmu.edu.cn+86 139 8603 9131

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Apr 17, 2026